Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Leuk Lymphoma. 2019 Jan 10;60(8):2062–2066. doi: 10.1080/10428194.2018.1562184

Figure 2.

Figure 2.

Kaplan-Meier Curves for Progression-free Survival and Overall Survival for ATL vs. non-ATL histologies. The median PFS (top panel) for ATL and non-ATL histologies was 5.7 months (95% CI: 0.5 – 51.0 months) and 6.8 months (95% CI: 4.3 – 26.4 months), respectively (p=0.41). The median OS (bottom panel) for ATL and non-ATL histologies was 15.3 months (95% CI: 0.5 – 73.2 months) and 27.6 months (95% CI: 5.0 months – undefined), respectively (p=0.11).